Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers.

Though CAR T cells have been effective against certain blood cancers, they have not been for solid tumors. Now, a new form of ...

Find 14 early 2000s cars built to outlast planned obsolescence, from Honda Civics hitting 300k miles to Toyota 4Runners still ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance in an area where CAR-T cells have long struggled. But significant ...

Sana Biotechnology Inc. (NASDAQ: SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana Biotechnology appointed Brian Piper as Executive Vice President and Chief ...

Neoadjuvant pembrolizumab (3 doses) in stage I–III disease yielded a 71% pCR rate and only one melanoma-specific survival event at 3 years post-resection. Experts discuss the SWOG S1512 trial of ...

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as ...

When a company claims to have created what’s essentially the holy grail of batteries, there are bound to be some questions.

Most surprisingly, the Uncharted is the first front-wheel-drive Subaru sold in the United States since the Impreza switched ...